greeksoup/ stock research

Healthpeak Properties (DOC) FY2021 results: revenue $1.9 billion, up 15.3% on the year

Healthpeak Properties, Inc. (DOC) reported revenue of $1.9 billion for fiscal 2021, the year ended 31 December 2021, up 15.3% on the year before. Net income was $506 million, up 22.2%, and diluted earnings per share $0.93. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2022.

Revenue
$1.9 billion
+15.3% on the year
FY2014FY2021
Operating margin
8.3%
-3.9% a year earlier
FY2014FY2021
Net income
$506 million
+22.2% on the year
FY2014FY2021
Diluted EPS
$0.93
+20.8% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q3 FY2021 · Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue1,8961,6451,240+15.3%
Cost of revenue773783405-1.2%
Gross profit1,123862835+30.2%
Gross margin59.2%52.4%67.3%
Operating income157-64.469.7
Operating margin8.3%-3.9%5.6%
Interest expense158218218-27.6%
Pre-tax income128218-8.6-41.0%
Income tax-3.3-9.4-5.5
Effective tax rate-2.5%-4.3%n/a
Net income50641445.5+22.2%
Net margin26.7%25.1%3.7%
Diluted EPS$0.93$0.77$0.09+20.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow795758846+4.9%
Capital expenditure760789677-3.7%
Free cash flow35.5-30.5169
Free cash flow margin1.9%-1.9%13.6%
Cash from investing531-1,008-1,449
Cash from financing-1,289246647
Depreciation and amortisation684554435+23.5%
Share-based compensation18.217.418.2+4.8%
Buybacks12.810.55.0+22.0%
Dividends paid650787720-17.4%
Dividend per share$1.20$1.48$1.48-18.9%
Diluted shares, weighted539m531m489m+1.5%
Shares outstanding at period end539m538m505m+0.1%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity6,5156,7346,085-3.2%
Non-controlling interest543556582-2.3%
Redeemable equity87.357.411.1+52.2%
Debt6,1706,6176,299-6.8%
Other liabilities1,9411,9561,055-0.7%
Total liabilities and equity15,25815,92014,033-4.2%
Goodwill18.018.017.00.0%
Intangible assets520520260-0.0%
Loans416195191+112.8%
Cash and equivalents15844.280.4+257.9%
Other assets14,14615,14313,485-6.6%
Total assets15,25815,92014,033-4.2%

10-K for the year ended 31 December 2021, filed 9 February 2022: the filing.